삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

소화기내과 곽금연 교수

진료분야
간암, 간경화, 급성간염, 만성간염, 지방간, 간질환
진료일정 04 月
날짜
월
01
화
02
수
03
목
04
금
05
토
06
일
07
월
08
화
09
수
10
목
11
금
12
토
13
일
14
월
15
화
16
수
17
목
18
금
19
토
20
일
21
월
22
화
23
수
24
목
25
금
26
토
27
일
28
월
29
화
30
오전
오후
진료일정 05 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2005.02 서울대학교 의학과 박사
2003.02 서울대학교 의학과 석사
1997.02 서울대학교 의학과 학사

경력

경력
2021.04 ~현재 성균관대학교 의과대학 내과 교수
2006.09 ~현재 삼성서울병원 소화기내과 전문의
2015.04 ~ 2021.03 성균관대학교 의과대학 내과 부교수
2011.03 ~ 2015.03 성균관대학교 의과대학 내과 조교수
2007.03 ~ 2011.02 삼성서울병원 내과 임상조교수
2008.08 ~ 2010.07 Columbia University 연수
2006.09 ~ 2007.02 삼성서울병원 내과 임상전임강사
2005.03 ~ 2006.02 서울대학교 병원 촉탁의
2004.03 ~ 2005.02 서울시립보라매 병원 전담의
2002.03 ~ 2004.02 서울대학교 병원 전임의
1998.03 ~ 2002.02 서울대학교 병원 전공의
1997.03 ~ 1998.02 서울대학교 병원 수련의

학회활동

학회활동
대한간학회회원
대한내과학회회원
대한소화기학회회원
논문
  • BMC GASTROENTEROL 2023 10.1186/s12876-023-02996-w Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data Sinn, DH; Kang, DB; Park, Y; Kim, H; Hong, YS; Cho, JH; Gwak, GY
    View PubMed
  • JHEP REP 2023 10.1016/j.jhepr.2023.100810 Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma Song, BG; Choi, SC; Goh, MJ; Kang, WS; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
    View PubMed
  • CLIN GASTROENTEROL H 2023 10.1016/j.cgh.2022.11.035 Letter to the Editor: Nonalcoholic Fatty Liver Disease Without Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome Reply Sinn, DH; Kang, D; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • CLIN GASTROENTEROL H 2023 10.1016/j.cgh.2022.09.014 Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome Sinn, DH; Kang, D; Choi, SC; Hong, YS; Zhao, D; Guallar, E; Park, Y; Cho, J; Gwak, GY
    View PubMed
  • PLOS ONE 2023 10.1371/journal.pone.0288820 Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study Sinn, DH; Kang, D; Guallar, E; Choi, SC; Hong, YS; Park, Y; Cho, J; Gwak, GY
    View PubMed
  • WORLD J GASTROENTERO 2023 10.3748/wjg.v29.i24.3843 Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B Park, Y; Kang, D; Sinn, DH; Kim, H; Hong, YS; Cho, J; Gwak, GY
    View PubMed
  • LIVER INT 2023 10.1111/liv.15632 Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII Song, BG; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW; Sinn, DH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-36668-2 Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B Oh, JH; Park, Y; Goh, MJ; Sinn, DH; Ahn, SB; Kang, WS; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-31686-6 Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study Park, Y; Sinn, DH; Kim, K; Gwak, GY
    View PubMed
  • ALIMENT PHARM THER 2023 10.1111/apt.17403 Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children - authors' reply Park, Y; Sinn, DH; Gwak, GY
    View PubMed
  • GUT LIVER 2023 10.5009/gnl220420 Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study Chang, JI; Kim, JH; Sinn, DH; Cho, JY; Kim, KM; Oh, JH; Park, Y; Sohn, W; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • GUT LIVER 2023 10.5009/gnl220337 Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis Goh, MJ; Kim, J; Chang, WH; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Kang, WS
    View PubMed
  • LIVER CANCER 2023 10.1159/000529635 Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors Goh, MJ; Park, HC; Yu, JI; Kang, WS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Sinn, DH; Choi, MS
    View PubMed
  • ALIMENT PHARM THER 2023 10.1111/apt.17342 Letter: hereditary role in non-alcoholic fatty liver disease - authors' reply Park, Y; Sinn, DH; Gwak, GY
    View PubMed
  • ALIMENT PHARM THER 2022 10.1111/apt.17257 The association of non-alcoholic fatty liver disease between parents and adolescent children Park, Y; Sinn, DH; Kim, K; Gwak, GY
    View PubMed
  • ACS OMEGA 2022 10.1021/acsomega.2c02926 Proteome Multimarker Panel for the Early Detection of Hepatocellular Carcinoma: Multicenter Derivation, Validation, and Comparison Kim, JY; Kim, J; Lim, YS; Gwak, GY; Yeo, IJ; Kim, Y; Lee, J; Shin, D; Lee, JH; Kim, Y
    View PubMed
  • HEPATOLOGY 2022 10.1002/hep.32678 Reply: NAFLD and sarcopenia: Association or causation? Sinn, DH; Kang, D; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • SCAND J GASTROENTERO 2022 10.1080/00365521.2022.2093124 Imaging features of hepatobiliary MRI and the risk of hepatocellular carcinoma development Chang, JI; Sinn, DH; Jeong, WK; Hwang, JA; Won, HY; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOLOGY 2022 10.1002/hep.32578 Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study Sinn, DH; Kang, D; Kang, M; Guallar, E; Hong, YS; Lee, KH; Park, J; Cho, J; Gwak, GY
    View PubMed
  • KOREAN J INTERN MED 2022 10.3904/kjim.2021.452 Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea Song, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-11736-1 Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy Goh, MJ; Kang, W; Jeong, WK; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.888755 Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC
    View PubMed
  • BMC MED 2022 10.1186/s12916-021-02215-x Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study Sinn, DH; Kang, D; Guallar, E; Hong, YS; Cho, J; Gwak, GY
    View PubMed
  • GENOME MED 2022 10.1186/s13073-021-00995-8 Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial Hong, JY; Cho, HJ; Sa, JK; Liu, XQ; Ha, SY; Lee, T; Kim, H; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, HC; Kang, TW; Rhim, H; Lee, SJ; Cristescu, R; Lee, J; Paik, YH; Lim, HY
    View PubMed
  • EUR J GASTROEN HEPAT 2022 10.1097/MEG.0000000000001915 Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase Seong, G; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • CLIN GASTROENTEROL H 2022 10.1016/j.cgh.2021.04.045 Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate Byun, KS; Choi, J; Kim, JH; Lee, YS; Lee, HC; Kim, YJ; Yoo, BC; Kwon, SY; Gwak, GY; Lim, YS
    View PubMed
  • EUR J GASTROEN HEPAT 2021 10.1097/MEG.0000000000002158 Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease Sinn, DH; Kang, D; Cho, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • SCAND J GASTROENTERO 2021 10.1080/00365521.2021.1988700 Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B Goh, MJ; Kang, W; Kim, KM; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • DIGEST DIS SCI 2021 10.1007/s10620-021-07312-8 Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels Chang, JI; Sinn, DH; Cho, H; Kim, S; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0255624 Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study Sinn, DH; Kang, D; Hong, YS; Koh, KC; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • HEPATOLOGY 2021 10.1002/hep.32034 The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study Park, Y; Sinn, DH; Oh, JH; Goh, MJ; Kim, K; Kang, W; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Gwak, GY
    View PubMed
  • J VIRAL HEPATITIS 2021 10.1111/jvh.13572 Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response Na, JE; Sinn, DH; Lee, JH; Jang, HJ; Baek, SY; Kim, KA; Kang, WS; Gwak, GY; Paik, YH; Kim, YJ; Choi, MS; Yoon, JH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOL INT 2021 10.1007/s12072-021-10205-7 Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy Oh, JH; Lee, HW; Sinn, DH; Park, JY; Kim, BK; Kim, SU; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2021.03.030 Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure Kim, JE; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOL COMMUN 2021 10.1002/hep4.1752 Inclusive Quantification Assay of Serum Des-gamma-Carboxyprothrombin Proteoforms for Hepatocellular Carcinoma Surveillance by Targeted Mass Spectrometry Lee1, J; Lim, YS; Lee, JH; Gwak, GY; Do, M; Yeo, I; Shin, D; Han, D; Park, T; Kim, Y
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0246143 Survival in untreated hepatocellular carcinoma: A national cohort study Kim1, YA; Kang, D; Moon, H; Sinn, D; Kang, M; Woo, SM; Chang, YJ; Park, B; Kong, SY; Guallar, E; Shin, SY; Gwak, G; Back, JH; Lee, ES; Cho, J
    View PubMed
  • AM J GASTROENTEROL 2021 10.14309/ajg.0000000000000966 Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study Sinn1, DH; Kang, D; Guallar, E; Chang, Y; Ryu, S; Zhao, D; Hong, YS; Cho, J; Gwak, GY
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2020.10.030 A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients Song1, BG; Kim, MJ; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2021 10.14309/ctg.0000000000000290 Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance Park1, Y; Lee, JH; Sinn, DH; Park, JY; Kim, MA; Kim, YJ; Yoon, JH; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • LIVER CANCER 2021 10.1159/000512239 Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea Goh1, MJ; Oh, JH; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.1.12 Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma Lee1, JS; Chon, YE; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Han, KH; Kang, W; Choi, MS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Kim, HY; Kim, TH; Yoo, K; Ha, Y; Kim, MN; Lee, JH; Hwang, SG; Kim, SS; Cho, HJ; Cheong, JY; Cho, SW; Park, SH; Heo, NY; Hong, YM; Yoon, KT; Cho, M; Park, JG; Kang, MK; Park, SY; Kweon, YO; Tak, WY; Jang, SY; Sinn, DH; Kim, SU
    View PubMed
  • SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1866063 Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal Song1, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0016 Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • INT J EPIDEMIOL 2020 10.1093/ije/dyaa089 Risk of hepatocellular carcinoma in individuals without traditional risk factors development and validation of a novel risk score Sinn1, DH; Kang, D; Cho, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238 Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06591-x Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events Oh1, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13279 Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients Kim1, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13304 Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study Hong1, CY; Sinn, DH; Kang, D; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13306 Long-term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients-Functional cure unlikely Cho1, JY; Sohn, W; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, CG
    View PubMed
  • TRANSPL P 2020 10.1016/j.transproceed.2020.01.037 Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma Song1, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS
    View PubMed
  • J CLIN ENDOCR METAB 2020 10.1210/clinem/dgz040 Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study Sinn1, DH; Kang, D; Cho, SJ; Chang, Y; Ryu, S; Bin Song, Y; Paik, SW; Hong, YS; Zhao, D; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2017.231 Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis Kim1, J; Kang, CI; Gwak, GY; Chung, DR; Peck, KR; Song, JH
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.040 Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14750 Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOL INT 2019 10.1007/s12072-019-09975-y The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015 Jang1, ES; Ki, M; Choi, HY; Kim, KA; Jeong, SH; Jang, ES; Ki, M; Gwak, GY; Kim, KA; Kim, GA; Kim, DY; Kim, DJ; Kim, MW; Kim, SE; Kim, YS; Kim, YS; Kim, IH; Kim, CW; Kim, HD; Kim, HJ; Park, NH; Baik, SK; Suh, JI; Song, BC; Song, IH; Yeon, JE; Lee, BS; Lee, YJ; Jung, YK; Chung, WJ; Cho, SB; Cho, EY; Cho, HC; Cheon, GJ; Chae, HB; Choi, DH; Choi, SK; Choi, HY; Tak, WY; Heo, J; Jeong, SH
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14856 Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study Sinn1, DH; Kang, D; Chang, Y; Ryu, S; Cho, SJ; Paik, SW; Song, YB; Pastor-Barriuso, R; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • EUR J ENDOCRINOL 2019 10.1530/EJE-19-0143 Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study Sinn1, DH; Kang, D; Choi, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • J HEPATOL 2019 10.1016/j.jhep.2019.02.021 Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial Lim1, YS; Gwak, GY; Choi, J; Lee, YS; Byun, KS; Kim, YJ; Yoo, BC; Kwon, SY; Lee, HC
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-5508-5 Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study Sinn1, DH; Kang, D; Kang, M; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0213547 Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment? Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CANCER IMMUNOL IMMUN 2019 10.1007/s00262-018-2247-4 Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up Lee1, JH; Lee, JH; Lim, YS; Yeon, JE; Song, TJ; Yu, SJ; Gwak, GY; Kim, KM; Kim, YJ; Lee, JW; Yoon, JH
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0210730 Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
    View PubMed
  • ANN SURG 2018 10.1097/SLA.0000000000002318 Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors Han1, S; Yang, JD; Sinn, DH; Kim, JM; Choi, GS; Jung, G; Ahn, JH; Kim, S; Ko, JS; Gwak, MS; Kwon, CHD; Leise, MD; Gwak, GY; Heimbach, JK; Kim, GS
    View PubMed
  • EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226 Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e264 Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study Kim1, SE; Jang, ES; Ki, M; Gwak, GY; Kim, KA; Kim, GA; Kim, DY; Kim, DJ; Kim, MW; Kim, YS; Kim, YS; Kim, IH; Kim, CW; Kim, HD; Kim, HJ; Park, NH; Baik, SK; Suh, JI; Song, BC; Song, IH; Yeon, JE; Lee, BS; Lee, YJ; Jung, YK; Chung, WJ; Cho, SB; Cho, EY; Cho, HC; Cheon, GJ; Chae, HB; Choi, D; Choi, SK; Choi, HY; Tak, WY; Heo, J; Jeong, SH
    View PubMed
  • LIVER INT 2018 10.1111/liv.13732 Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CAN J GASTROENTEROL HEPATOL 2018 10.1155/2018/7926923 Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography Lee1, MW; Lim, HK; Rhim, H; Cha, DI; Kang, TW; Song, KD; Min, JH; Gwak, GY; Kim, S; Lu, DSK
    View PubMed
  • HEPATOLOGY 2018 10.1002/hep.29627 MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis Caviglia1, JM; Yan, J; Jang, MK; Gwak, GY; Affo, S; Yu, LX; Olinga, P; Friedman, RA; Chen, X; Schwabe, RF
    View PubMed
  • SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895 Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment? Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J GASTROEN HEPATOL 2018 10.1111/jgh.14042 Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study Min1, YW; Kim, Y; Gwak, GY; Gu, S; Kang, D; Cho, SJ; Guallar, E; Cho, J; Sinn, DH
    View PubMed
  • DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6 Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-23014-0 Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study Jang1, HR; Kang, D; Sinn, DH; Gu, S; Cho, SJ; Lee, JE; Huh, W; Paik, SW; Ryu, S; Chang, Y; Shafi, T; Lazo, M; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • LIVER INT 2018 10.1111/liv.13489 Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J HEPATOL 2017 Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study Sinn1, DH; Kang, D; Jang, HR; Gu, S; Cho, SJ; Paik, SW; Ryu, S; Chang, Y; Lazo, M; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8 Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOLOGY 2017 10.1002/hep.29187 Monotherapy With Tenofovir Disoproxil Fumarate for Multiple Drug-Resistant Chronic Hepatitis B: 3-Year Trial Lim1, YS; Lee, YS; Gwak, GY; Byun, KS; Kim, YJ; Choi, J; An, J; Lee, HC; Yoo, BC; Kwon, SY
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.17072 Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial Yu1, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW
    View PubMed
  • J LAPAROENDOSC ADV S 2017 10.1089/lap.2016.0575 Laparoscopic Liver Resection of Hepatocellular Carcinoma with a Tumor Size Larger Than 5 cm: Review of 45 Cases in a Tertiary Institution Gil1, E; Kwon, CHD; Kim, JM; Choi, GS; Heo, JS; Cho, W; Gwak, MS; Gwak, GY; Joh, JW
    View PubMed
  • HEPATOLOGY 2017 10.1002/hep.28916 Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • GUT LIVER 2017 10.5009/gnl16403 A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2016.096 Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response Cho1, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH
    View PubMed
  • J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Aliment Pharmacol Ther. 2017 Feb;45(4):577-578. doi: 10.1111/apt.13911. Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia - authors' reply Ahn JS11, Sinn DH1, Son HJ1,2, Gwak GY1.
    View PubMed
  • Gut. 2017 Feb;66(2):323-329. doi: 10.1136/gutjnl-2016-311854. Epub 2016 Sep 6. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study Sinn DH11, Kang D2, Chang Y3,4,5, Ryu S3,4,5, Gu S6, Kim H6, Seong D2, Cho SJ7, Yi BK2,8, Park HD9, Paik SW1, Song YB1,10, Lazo M10, Lima JA10, Guallar E10, Cho J2,3,5,10, Gwak GY1.
    View PubMed
  • Aliment Pharmacol Ther. 2017 Jan;45(2):345-353. doi: 10.1111/apt.13866. Epub 2016 Nov 18. Non-alcoholic fatty liver diseases and risk of colorectal neoplasia Ahn JS11, Sinn DH1, Min YW1, Hong SN1, Kim HS2, Jung SH2, Gu S3, Rhee PL1, Paik SW1, Son HJ4, Gwak GY1.
    View PubMed
  • Oncotarget. 2017 Jan 10;8(2):2076-2082. doi: 10.18632/oncotarget.10502. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma Joung JG11, Ha SY2, Bae JS1, Nam JY1,3, Gwak GY4, Lee HO1,5, Son DS1,6, Park CK2, Park WY1,3,5.
    View PubMed
  • Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666. The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma Kim JH11, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
    View PubMed
  • Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • PLoS One. 2016 Nov 15;11(11):e0165722. doi: 10.1371/journal.pone.0165722. eCollection 2016. Survival Analysis of Single Large (> 5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B Cho Y11,2, Sinn DH3, Yu SJ1, Gwak GY3, Kim JH4, Yoo YJ4, Jun DW5, Kim TY6, Lee HY5, Cho EJ1, Lee JH1, Kim YJ1, Yoon JH1.
    View PubMed
  • Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527. Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma Kim JH11, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients? Kim KM11, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.
    View PubMed
  • Eur Radiol. 2016 Oct;26(10):3437-46. doi: 10.1007/s00330-015-4190-5. Epub 2016 Jan 8. Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma Kang TW11, Rhim H2, Lee J1, Song KD1, Lee MW1, Kim YS1, Lim HK1, Jang KM1, Kim SH1, Gwak GY3, Jung SH4.
    View PubMed
  • Gut. 2016 Oct;65(10):1721-32. doi: 10.1136/gutjnl-2015-310212. Epub 2016 May 11. Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis Suk KT11, Mederacke I2, Gwak GY3, Cho SW4, Adeyemi A5, Friedman R6, Schwabe RF7.
    View PubMed
  • Gastroenterology. 2016 Sep;151(3):481-488.e1. doi: 10.1053/j.gastro.2016.06.001. Epub 2016 Jun 7. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis Sinn DH11, Cho SJ2, Gu S3, Seong D4, Kang D5, Kim H6, Yi BK7, Paik SW1, Guallar E8, Cho J8, Gwak GY9.
    View PubMed
  • Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368. Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index Lee K11, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735. Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study Kim JH11, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
    View PubMed
  • Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.
    View PubMed
  • Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
    View PubMed
  • PLoS One. 2016 May 5;11(5):e0154986. doi: 10.1371/journal.pone.0154986. eCollection 2016. Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis Cho YY11, Lee M1, Kim HC2, Chung JW2, Kim YH3, Gwak GY4, Bae SH5, Kim do Y6, Heo J7, Kim YJ1.
    View PubMed
  • World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785. Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease Hong YS11, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • J Clin Lipidol. 2016 Mar-Apr;10(2):289-98. doi: 10.1016/j.jacl.2015.11.017. Epub 2015 Dec 2. The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population Yang MH11, Sung J2, Gwak GY3.
    View PubMed
  • Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease Ahn JM11, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods Kim JM11, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(1):e2400. doi: 10.1097/MD.0000000000002400. Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents Shin JH11, Kwon HJ, Jang HR, Lee JE, Gwak GY, Huh W, Jung SH, Lee JH, Kim YG, Kim DJ, Oh HY.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578. Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis Sinn DH11, Cho SJ, Gwak GY, Cho J, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW.
    View PubMed
  • Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28. Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors Kim HJ11, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015. Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels Ahn JM11,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy Lee JY11, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.
    View PubMed
  • J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16. Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels Lee J11, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
    View PubMed
  • Medicine (Baltimore). 2015 Oct;94(43):e1846. doi: 10.1097/MD.0000000000001846. Factors Associated With Age-related Hearing Impairment A Retrospective Cohort Study Moon IJ11, Byun H, Woo SY, Gwak GY, Hong SH, Chung WH, Cho YS.
    View PubMed
  • Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load Sinn DH11, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
    View PubMed
  • Radiology. 2015 Jul;276(1):274-85. doi: 10.1148/radiol.15141215. Epub 2015 Feb 25. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance Kang TW11, Lim HK1, Lee MW1, Kim YS1, Rhim H1, Lee WJ1, Gwak GY1, Paik YH1, Lim HY1, Kim MJ1.
    View PubMed
  • Autophagy. 2015;11(7):1187-8. doi: 10.1080/15548627.2015.1054593. Comment on: HMGB1-dependent and -independent autophagy Huebener P11, Gwak GY, Schwabe RF.
    View PubMed
  • J Viral Hepat. 2015 Jun;22(6):539-50. doi: 10.1111/jvh.12356. Epub 2014 Nov 7. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load Sohn W11, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Gastroenterology. 2015 Jun;148(7):1383-91.e6. doi: 10.1053/j.gastro.2015.02.055. Epub 2015 Mar 4. Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma Lee JH11, Lee JH2, Lim YS3, Yeon JE4, Song TJ5, Yu SJ2, Gwak GY1, Kim KM3, Kim YJ2, Lee JW6, Yoon JH7.
    View PubMed
  • J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13. Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors Sohn W11, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Radiology. 2015 May;275(2):599-608. doi: 10.1148/radiol.14141568. Epub 2015 Jan 5. Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study Song KD11, Lim HK, Rhim H, Lee MW, Kim YS, Lee WJ, Paik YH, Gwak GY, Kim JM, Kwon CH, Joh JW.
    View PubMed
  • Transplant Proc. 2015 Apr;47(3):709-17. doi: 10.1016/j.transproceed.2014.10.057. Renal Outcomes After Liver Transplantation in Fulminant Hepatitis A With Acute Kidney Injury: Comparison With Hepatorenal Syndrome Park JY11, Gwak GY2, Kim JM3, Oh HJ4, Yi NJ5, Suh KS5, Kim DK1, Lim CS6, Kim YS1, Lee JP7.
    View PubMed
  • PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015. Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread Sinn DH11, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11. Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women Sinn DH11, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses Huang CS1, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.
    View PubMed
  • Korean J Intern Med. 2015 Jan;30(1):32-41. doi: 10.3904/kjim.2015.30.1.32. Epub 2014 Dec 30. Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients Kim HJ11, Cho JY1, Kim YJ1, Gwak GY1, Paik YH1, Choi MS1, Koh KC1, Paik SW1, Yoo BC1, Lee JH1.
    View PubMed
  • Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409. Epub 2014 Mar 10. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease Cho JY11, Paik YH1, Sohn W1, Cho HC2, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • PLoS One. 2014 Nov 5;9(11):e112184. doi: 10.1371/journal.pone.0112184. eCollection 2014. Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort Sinn DH11, Gwak GY1, Cho J2, Paik SW1, Yoo BC1.
    View PubMed
  • Tumori. 2014 Nov-Dec;100(6):645-51. doi: 10.1700/1778.19270. Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications Yu JI1, Cho JY, Park HC, Lim do H, Gwak GY, Paik SW.
    View PubMed
  • Aliment Pharmacol Ther. 2014 Sep;40(6):695-704. doi: 10.1111/apt.12875. Epub 2014 Jul 30. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study Min YW11, Lim KS, Min BH, Gwak GY, Paik YH, Choi MS, Lee JH, Kim JJ, Koh KC, Paik SW, Yoo BC, Rhee PL.
    View PubMed
  • Gut Liver. 2014 Sep;8(5):543-51. doi: 10.5009/gnl13356. Epub 2014 Jul 25. Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors Sohn W11, Choi MS1, Cho JY1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma Shin JU11, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.
    View PubMed
  • Hepatogastroenterology. 2014 Sep;61(134):1704-11. Hepatitis B Virus Reactivation During Anti-Cancer Chemotherapy in Patients with Past Hepatitis B Virus Infection Kim E1, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • J Korean Med Sci. 2014 Aug;29(8):1113-9. doi: 10.3346/jkms.2014.29.8.1113. Epub 2014 Jul 30. Relationship of Liver Stiffness and Controlled Attenuation Parameter Measured by Transient Elastography with Diabetes Mellitus in Patients with Chronic Liver Disease Ahn JM11, Paik YH1, Kim SH1, Lee JH1, Cho JY1, Sohn W1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12. HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma Sohn W11, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease Sinn DH11, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.
    View PubMed
  • J Gastroenterol Hepatol. 2014 May;29(5):1043-8. doi: 10.1111/jgh.12504. Long- term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching Min YW11, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS.
    View PubMed
  • Liver Int. 2014 May;34(5):695-9. doi: 10.1111/liv.12374. Epub 2013 Nov 24. Risk factor of community-onset spontaneous bacterial peritonitis caused by fluoroquinolone-resistant Escherichia coli in patients with cirrhosis Kim J11, Kang CI, Joo EJ, Ha YE, Cho SY, Gwak GY, Chung DR, Peck KR, Song JH.
    View PubMed
  • Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma Cho JY11, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Cell Metab. 2014 Mar 4;19(3):539-47. doi: 10.1016/j.cmet.2014.01.014. High-Mobility Group Box 1 Is Dispensable for Autophagy, Mitochondrial Quality Control, and Organ Function In Vivo Huebener P11, Gwak GY2, Pradere JP1, Quinzii CM3, Friedman R4, Lin CS5, Trent CM6, Mederacke I1, Zhao E7, Dapito DH8, Lin Y8, Goldberg IJ6, Czaja MJ7, Schwabe RF9.
    View PubMed
  • Scand J Gastroenterol. 2014 Mar;49(3):373-80. doi: 10.3109/00365521.2013.871745. Epub 2013 Dec 19. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation Sohn W11, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Gut Liver. 2014 Jan;8(1):58-63. doi: 10.5009/gnl.2014.8.1.58. Epub 2013 Nov 21. Clinical Features, Image Findings, and Prognosis of Inflammatory Pseudotumor of the Liver: A Multicenter Experience of 45 Cases Park JY11, Choi MS1, Lim YS2, Park JW2, Kim SU3, Min YW1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Transplantation. 2013 Jun 15;95(11):1404-9. doi: 10.1097/TP.0b013e31828d1588. Steatosis Among Living Liver Donors Without Evidence of Fatty Liver on Ultrasonography: Potential Implications for Preoperative Liver Biopsy Ahn JS11, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • World J Gastroenterol. 2013;19(14):2256-61. doi: 10.3748/wjg.v19.i14.2256. Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels Sinn DH11, Gwak GY, Shin JU, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Hepatogastroenterology. 2013 Mar-Apr;60(122):328-32. Screening for Extrahepatic Metastases by Additional Staging Modalities is Required for Hepatocellular Carcinoma Patients Beyond Modified UICC Stage T1 Yi J11, Gwak GY, Sinn DH, Kim YJ, Kim HN, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • A comparison of clevudine and entecavir for treatment-na < ve patients with chronic hepatitis B: results after 2 years of treatment
  • Liver Int. 2012 Jul;32(6):937-44. doi: 10.1111/j.1478-3231.2011.02749.x. Epub 2012 Jan 20. Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease Park HN11, Sinn DH, Gwak GY, Kim JE, Rhee SY, Eo SJ, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • World J Gastroenterol. 2012 Jun 7;18(21):2654-60. doi: 10.3748/wjg.v18.i21.2654. Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma Min YW11, Gwak GY, Lee MW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Cancer Cell. 2012 Apr 17;21(4):504-16. doi: 10.1016/j.ccr.2012.02.007. Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4 Dapito DH11, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A, Bataller R, Lefkowitch JH, Bower M, Friedman R, Sartor RB, Rabadan R, Schwabe RF.
    View PubMed
  • Am J Gastroenterol. 2012 Apr;107(4):561-7. doi: 10.1038/ajg.2011.400. Epub 2011 Nov 22. Ultrasonographically Detected Non-Alcoholic Fatty Liver Disease Is an Independent Predictor for Identifying Patients With Insulin Resistance in Non-Obese, Non-Diabetic Middle-Aged Asian Adults Sinn DH11, Gwak GY, Park HN, Kim JE, Min YW, Kim KM, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • World J Gastroenterol. 2012 Feb 21;18(7):679-84. doi: 10.3748/wjg.v18.i7.679. Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway Gwak GY11, Moon TG, Lee DH, Yoo BC.
    View PubMed
  • Liver Transpl. 2011 Dec;17(12):1467-73. doi: 10.1002/lt.22432. Predictors of the feasibility of primary endoscopic management of biliary strictures after adult living donor liver transplantation Lee YY11, Gwak GY, Lee KH, Lee JK, Lee KT, Kwon CH, Joh JW, Lee SK.
    View PubMed
  • Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1643-7. doi: 10.5754/hge08631. Clinical Significance of Core Gene Mutations During the Course of Genotype C Chronic Hepatitis B Virus Infection Lee DH11, Gwak GY, Min BH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • Hepatogastroenterology. 2011 Jul-Aug;58(109):1291-5. doi: 10.5754/hge07389. Clinical Impact of the Development of YMDD Mutants in Hepatitis B Virus-Associated Glomerulonephritis Gwak GY11, Lee CY, Lee DH, Huh W, Koh KC, Kim YG.
    View PubMed
  • Hepatogastroenterology. 2011 Mar-Apr;58(106):522-8. The Correlation of Hepatitis B Virus Pre-S Mutation with Mitochondrial D-loop Mutations and Common Deletions in Hepatocellular Carcinoma Gwak GY11, Lee DH, Moon TG, Choi MS, Lee JH, Koh KC, Paik SW, Joh JW, Yoo BC.
    View PubMed
  • Hepatogastroenterology. 2010 Jul-Aug;57(101):801-6. The Efficacy of Combined Transarterial Chemoembolization and 3-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma with Main Portal Vein Thrombosis Park MK11, Gwak GY, Lim do H, Choo SW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • The Clinical Value of F-18-FDG PET/CT for Investigating Unexplained Serum AFP Elevation Following Interventional Therapy for Hepatocellular Carcinoma
  • Cancer Lett. 2008 Nov 28;271(2):314-22. doi: 10.1016/j.canlet.2008.06.019. Epub 2008 Jul 25. Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth Park SC11, Yoon JH, Lee JH, Yu SJ, Myung SJ, Kim W, Gwak GY, Lee SH, Lee SM, Jang JJ, Suh KS, Lee HS.
    View PubMed
  • Hepatogastroenterology. 2008 Nov-Dec;55(88):2028-32. The Correlation of Hepatitis B Virus Pre-S Mutation with Cellular Oxidative DNA Damage in Hepatocellular Carcinoma Gwak GY11, Lee DH, Moon TG, Choi MS, Lee JH, Koh KC, Paik SW, Park CK, Joh JW, Yoo BC.
    View PubMed
  • Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1721-4. Occult Hepatitis B Virus Infection in Chronic Hemodialysis Patients in Korea Gwak GY11, Huh W, Lee DH, Min BH, Koh KC, Kim JJ, Oh HY.
    View PubMed
  • Transplant Proc. 2007 Dec;39(10):3121-6. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy Gwak GY11, Huh W, Lee DH, Choi MS, Lee JH, Koh KC, Kim SJ, Joh JW, Oh HY.
    View PubMed
  • Clin Exp Rheumatol. 2007 Nov-Dec;25(6):888-9. Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen-negative patient with rheumatoid arthritis receiving low dose methotrexate Gwak GY11, Koh KC, Kim HY.
    View PubMed